RxDoctor Payments Data

Timothy Linker, MD

Family Medicine · Mason, OHNPI 1417955428

Payments from drug & device makers

$5,593in general payments, 2019–2025

Across 353 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$645
  • Lilly USA, LLC$533
  • AstraZeneca$472
  • Pfizer$338
  • Merck$272
  • plus $2K from 39 others

What the payments were for

  • Food & beverage$5,591100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,593 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$39,602
Medicare patients
147
Services billed
607

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate31$39,903
JardianceEmpagliflozin33$34,698
FarxigaDapagliflozin Propanediol20$31,810
EliquisApixaban25$22,533
JanumetSitagliptin Phos/Metformin Hcl11$17,657
OzempicSemaglutide15$14,201
SymbicortBudesonide/Formoterol Fumarate16$3,607
Atorvastatin Calcium210$1,643
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide112$1,468
SynthroidLevothyroxine Sodium34$1,326
Escitalopram Oxalate96$1,134
Pantoprazole Sodium109$1,031
Rosuvastatin Calcium81$951
Levothyroxine Sodium159$909
Albuterol Sulfate HfaAlbuterol Sulfate19$864

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$272$57,56042 claims
AstraZenecaFarxiga, Symbicort$472$35,41636 claims
Boehringer IngelheimJardiance$197$34,69833 claims
PfizerEliquis$338$22,53325 claims
Novo NordiskOzempic$645$14,20115 claims
AbbVieSynthroid$1,004$1,32634 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Mason

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →